The new generation of
Chimeric Antigen Receptors
At coding.bio, we use an AI-first approach to design new CARs, combined with our high-throughput screening platform to discover best-in-class CARs to power the cell therapy revolution.
Our ultimate goal is to provide curative therapeutics to as many patients as possible.
Our streamlined development approach allows for comprehensive discovery of novel CARs in three months time.
Machine Learning accelerates our discovery process by selecting best-in-class lead candidates for your target.
Build & Test
Our automated high-throughput wet-lab platform tests and optimises every domain of the CAR systematically and can assess thousands of CARs for functionality to identify best-in-class performers.
We are continuously looking for partners who would like to bring their CAR-based therapeutics to the next level. Our aim is to provide our partners with the best receptors to ensure successful clinical outcome.